Literature DB >> 22476585

Esophageal squamous cell carcinoma: assessing tumor angiogenesis using multi-slice CT perfusion imaging.

Tao Song1, Yu-Guang Shen, Na-Na Jiao, Xin-Hui Li, Hong-Tao Hu, Jin-Rong Qu, Xue-Jun Chen, Wen Feng, Xun Zhang, Hai-Liang Li.   

Abstract

OBJECTIVES: The purpose of this study was to investigate the correlation between multi-slice computed tomographic perfusion imaging (CTPI) parameters and immunohistologic markers of angiogenesis in esophageal squamous cell carcinoma (ESCC).
METHODS: Fifty patients with histologically proven esophageal squamous cell carcinoma were enrolled in this study. All subjects underwent multi-slice CT perfusion scan. The hemodynamic parameters of vascular tumor, including blood volume (BV), blood flow (BF), mean transit time (MTT) and permeability surface (PS) were generated. All the ESCC specimens were stained immunohistochemically to identify CD31 for quantification of microvessel density (MVD). CTPI parameters were correlated with MVD by using Pearson correlation analysis.
RESULTS: The value of CT perfusion parameters of ESCC were as follows: BF 116.71 ± 47.59 ml/100 g/min, BV 6.74 ± 2.70 ml/100 g, MTT 6.42 ± 2.84 s, PS 13.82 ± 6.25 ml/100 g/min. The mean MVD of all 50 tumor specimens was 34.44 ± 19.75. The PS values were significantly higher in ESCC patients with involvement of lymph node than those without involvement of lymph node (p < 0.01). Blood volume and permeability surface were positively correlated with MVD (p < 0.01), whereas no significant correlation was observed between MVD and BF or between MVD and MTT.
CONCLUSIONS: Blood volume and permeability surface were positively correlated with MVD. CTPI could reflect the angiogenesis in ESCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22476585     DOI: 10.1007/s10620-012-2149-9

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  37 in total

1.  Liver cancer: Targeted future options.

Authors:  Andreas Pircher; Michael Medinger; Joachim Drevs
Journal:  World J Hepatol       Date:  2011-02-27

2.  Tumor vascularity: a histological measure of angiogenesis and hypoxia.

Authors:  C M West; R A Cooper; J A Loncaster; D P Wilks; M Bromley
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

3.  Microvessel density of hepatocellular carcinoma: its relationship with prognosis.

Authors:  H C Sun; Z Y Tang; X M Li; Y N Zhou; B R Sun; Z C Ma
Journal:  J Cancer Res Clin Oncol       Date:  1999-07       Impact factor: 4.553

4.  The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus.

Authors:  G O Elpek; T Gelen; N H Aksoy; A Erdoğan; L Dertsiz; A Demircan; N Keleş
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

5.  Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.

Authors:  Dushyant V Sahani; Sanjeeva P Kalva; Leena M Hamberg; Peter F Hahn; Christopher G Willett; Sanjay Saini; Peter R Mueller; Ting-Yim Lee
Journal:  Radiology       Date:  2005-03       Impact factor: 11.105

6.  Head and neck squamous cell carcinoma: CT perfusion can help noninvasively predict intratumoral microvessel density.

Authors:  Lorraine Ash; Theodoros N Teknos; Dheerhaj Gandhi; Samip Patel; Suresh K Mukherji
Journal:  Radiology       Date:  2009-03-10       Impact factor: 11.105

7.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer.

Authors:  Christopher G Willett; Yves Boucher; Emmanuelle di Tomaso; Dan G Duda; Lance L Munn; Ricky T Tong; Daniel C Chung; Dushyant V Sahani; Sanjeeva P Kalva; Sergey V Kozin; Mari Mino; Kenneth S Cohen; David T Scadden; Alan C Hartford; Alan J Fischman; Jeffrey W Clark; David P Ryan; Andrew X Zhu; Lawrence S Blaszkowsky; Helen X Chen; Paul C Shellito; Gregory Y Lauwers; Rakesh K Jain
Journal:  Nat Med       Date:  2004-01-25       Impact factor: 53.440

8.  Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer.

Authors:  Alexander J Greenstein; Virginia R Litle; Scott J Swanson; Celia M Divino; Stuart Packer; Juan P Wisnivesky
Journal:  Cancer       Date:  2008-03-15       Impact factor: 6.860

9.  Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma.

Authors:  Andrew X Zhu; Nagaraj S Holalkere; Alona Muzikansky; Kerry Horgan; Dushyant V Sahani
Journal:  Oncologist       Date:  2008-02

Review 10.  Are tumours angiogenesis-dependent?

Authors:  H M W Verheul; E E Voest; R O Schlingemann
Journal:  J Pathol       Date:  2004-01       Impact factor: 7.996

View more
  3 in total

1.  Computed tomography (CT) perfusion as an early predictive marker for treatment response to neoadjuvant chemotherapy in gastroesophageal junction cancer and gastric cancer--a prospective study.

Authors:  Martin Lundsgaard Hansen; Eva Fallentin; Carsten Lauridsen; Ian Law; Birgitte Federspiel; Lene Bæksgaard; Lars Bo Svendsen; Michael Bachmann Nielsen
Journal:  PLoS One       Date:  2014-05-20       Impact factor: 3.240

Review 2.  Predicting the Response of Neoadjuvant Therapy for Patients with Esophageal Carcinoma: an In-depth Literature Review.

Authors:  Chang-Juan Tao; Gang Lin; Ya-Ping Xu; Wei-Min Mao
Journal:  J Cancer       Date:  2015-09-15       Impact factor: 4.207

3.  Assessing Microcirculation in Resectable Oesophageal Squamous Cell Carcinoma with Dynamic Contrast-enhanced MRI for Identifying Primary tumour and Lymphatic Metastasis.

Authors:  Yan-Li Chen; Yu Jiang; Tian-Wu Chen; Rui Li; Xiao-Ming Zhang; Fan Chen; Lan Wu; Jing Ou; Jian-Qiong Yang
Journal:  Sci Rep       Date:  2019-01-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.